Key result
High-capacity aerobic phenotypes lose augmented resting cardiac mitochondrial capacity following ischemia reperfusion.
Questions persistence of mitochondrial benefits in high-capacity runners post-ischemia-reperfusion; leaves open mechanisms of their disease resistance.
No takes yet. Share an insight, caveat, or question.
Alsahly et al. (2026) studied this question. High capacity aerobic running disease-resistant phenotypes lose their augmented resting cardiac mitochondrial capacity following ischemia reperfusion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: